Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis

被引:49
|
作者
Pierrot-Deseilligny, Charles [1 ]
Souberbielle, Jean-Claude [2 ]
机构
[1] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Serv Neurol 1, Paris, France
[2] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France
关键词
Epstein-Barr virus; genetics; multiple sclerosis; smoking; vitamin D; EPSTEIN-BARR-VIRUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SERUM 25-HYDROXYVITAMIN D; BONE-MINERAL DENSITY; ENVIRONMENTAL RISK-FACTORS; CENTRAL-NERVOUS-SYSTEM; PLACEBO-CONTROLLED TRIAL; REGULATORY T-CELLS; D-RECEPTOR GENE; 1,25-DIHYDROXYVITAMIN D-3;
D O I
10.1177/1756285612473513
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis (MS) is reviewed. Among the multiple recently discovered actions of vitamin D, an immunomodulatory role has been documented in experimental autoimmune encephalomyelitis and in humans. This action in the peripheral immune system is currently the main known mechanism through which vitamin D might influence MS, but other types of actions could be involved within the central nervous system. Furthermore, vitamin D insufficiency is widespread in temperate countries and in patients with MS at the earliest stages of the disease, suggesting that the deleterious effects related to vitamin D insufficiency may be exerted in these patients. In fact, many genetic and environmental risk factors appear to interact and contribute to MS. In genetics, several human leukocyte antigen (HLA) alleles (more particularly HLA-DRB1*1501) could favour the disease whereas some others could be protective. Some of the genes involved in vitamin D metabolism (e.g. CYP27B1) also play a significant role. Furthermore, three environmental risk factors have been identified: past Epstein-Barr virus infection, vitamin D insufficiency and cigarette smoking. Interactions between genetic and environmental risk or protective factors may occur during the mother's pregnancy and could continue during childhood and adolescence and until the disease is triggered in adulthood, therefore possibly modulating the MS risk throughout the first decades of life. Furthermore, some clinical findings already strongly suggest that vitamin D status influences the relapse rate and radiological lesions in patients with MS, although the results of adequately powered randomized clinical trials using vitamin D supplementation have not yet been reported. While awaiting these incontrovertible results, which might be long in coming, patients with MS who are currently in vitamin D insufficiency should be supplemented, at least for their general health status, using moderate doses of the vitamin.
引用
收藏
页码:81 / 116
页数:36
相关论文
共 50 条
  • [1] Assessment of evidence for a protective role of vitamin D in multiple sclerosis
    Hanwell, Heather E. C.
    Banwell, Brenda
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (02): : 202 - 212
  • [2] Vitamin D and Multiple Sclerosis
    Ho, Swui-Ling
    Alappat, Lini
    Awad, Atif B.
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2012, 52 (11) : 980 - 987
  • [3] Illuminating vitamin D effects on B cells - the multiple sclerosis perspective
    Rolf, Linda
    Muris, Anne-Hilde
    Hupperts, Raymond
    Damoiseaux, Jan
    IMMUNOLOGY, 2016, 147 (03) : 275 - 284
  • [4] Vitamin D and remyelination in multiple sclerosis
    Matias-Guiu, J.
    Oreja-Guevara, C.
    Matias-Guiu, J. A.
    Gomez-Pinedo, U.
    NEUROLOGIA, 2018, 33 (03): : 177 - 186
  • [5] Vitamin D and multiple sclerosis: An update
    Pierrot-Deseilligny, Charles
    Souberbielle, Jean-Claude
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 14 : 35 - 45
  • [6] Pathogenesis of Pediatric Multiple Sclerosis
    Vargas-Lowy, David
    Chitnis, Tanuja
    JOURNAL OF CHILD NEUROLOGY, 2012, 27 (11) : 1394 - 1407
  • [7] Immunomodulatory effects of Vitamin D in multiple sclerosis
    Correale, Jorge
    Celica Ysrraelit, Mara
    Ines Gaitan, Maria
    BRAIN, 2009, 132 : 1146 - 1160
  • [8] Vitamin D in multiple sclerosis: implications for assessment and treatment
    Holmoy, Trygve
    Kampman, Margitta T.
    Smolders, Joost
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (09) : 1101 - 1112
  • [9] A Brief Review of the Effects of Vitamin D on Multiple Sclerosis
    Miclea, Andrei
    Bagnoud, Maud
    Chan, Andrew
    Hoepner, Robert
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [10] Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics
    Simon, Kelly C.
    Munger, Kassandra L.
    Ascherio, Alberto
    CURRENT OPINION IN NEUROLOGY, 2012, 25 (03) : 246 - 251